Literature DB >> 25007010

Baseline levels, and changes over time in body mass index and fasting insulin, and their relationship to change in metabolic trait clustering.

Martin K Rutter1, Lisa M Sullivan, Caroline S Fox, Peter W F Wilson, David M Nathan, Ramachandran S Vasan, Ralph B D'Agostino, James B Meigs.   

Abstract

BACKGROUND: Multiple abnormal metabolic traits are found together or "cluster" within individuals more often than is predicted by chance. The individual and combined role of adiposity and insulin resistance (IR) on metabolic trait clustering is uncertain. We tested the hypothesis that change in trait clustering is a function of both baseline level and change in these measures.
METHODS: In 2616 nondiabetic Framingham Offspring Study participants, body mass index (BMI) and fasting insulin were related to a within-person 7-year change in a trait score of 0-4 Adult Treatment Panel III metabolic syndrome traits (hypertension, high triglycerides, low high-density lipoprotein cholesterol, hyperglycemia).
RESULTS: At baseline assessment, mean trait score was 1.4 traits, and 7-year mean (SEM) change in trait score was +0.25 (0.02) traits, P<0.0001. In models with BMI predictors only, for every quintile difference in baseline BMI, the 7-year trait score increase was 0.14 traits, and for every quintile increase in BMI during 7-year follow-up, the trait score increased by 0.3 traits. Baseline level and change in fasting insulin were similarly related to trait score change. In models adjusted for age-sex-baseline cluster score, 7-year change in trait score was significantly related to both a 1-quintile difference in baseline BMI (0.07 traits) and fasting insulin (0.18 traits), and to both a 1-quintile 7-year increase in BMI (0.21 traits) and fasting insulin (0.18 traits).
CONCLUSIONS: Change in metabolic trait clustering was significantly associated with baseline levels and changes in both BMI and fasting insulin, highlighting the importance of both obesity and IR in the clustering of metabolic traits.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25007010      PMCID: PMC4209491          DOI: 10.1089/met.2013.0148

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  48 in total

1.  The myth of the metabolic syndrome.

Authors:  Edwin A M Gale
Journal:  Diabetologia       Date:  2005-07-16       Impact factor: 10.122

2.  Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

Authors:  J B Meigs; R B D'Agostino; P W Wilson; L A Cupples; D M Nathan; D E Singer
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

3.  Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.

Authors:  Anthony J G Hanley; Andrew J Karter; Ken Williams; Andreas Festa; Ralph B D'Agostino; Lynne E Wagenknecht; Steven M Haffner
Journal:  Circulation       Date:  2005-12-13       Impact factor: 29.690

4.  Correct homeostasis model assessment (HOMA) evaluation uses the computer program.

Authors:  J C Levy; D R Matthews; M P Hermans
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

5.  The World Health Report 1997--conquering suffering, enriching humanity.

Authors: 
Journal:  World Health Forum       Date:  1997

6.  Relative risks of the metabolic syndrome according to the degree of insulin resistance in apparently healthy Korean adults.

Authors:  Seung-Ha Park; Won-Young Lee; Eun-Jung Rhee; Woo-Kyu Jeon; Byung-Ik Kim; Seung-Ho Ryu; Sun-Woo Kim
Journal:  Clin Sci (Lond)       Date:  2005-06       Impact factor: 6.124

7.  Clustering of metabolic factors and coronary heart disease.

Authors:  P W Wilson; W B Kannel; H Silbershatz; R B D'Agostino
Journal:  Arch Intern Med       Date:  1999-05-24

8.  Changes in blood pressure and plasma catecholamine levels during prolonged hyperinsulinemia.

Authors:  Werner Kern; Achim Peters; Jan Born; Horst L Fehm; Bernd Schultes
Journal:  Metabolism       Date:  2005-03       Impact factor: 8.694

9.  Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

Authors:  Earl S Ford
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

Review 10.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

View more
  6 in total

Review 1.  Metabesity and urological cancers.

Authors:  Ali Atan
Journal:  Turk J Urol       Date:  2017-12-01

2.  Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.

Authors:  G C Kabat; W Y-Y Wu; J W Bea; C Chen; L Qi; M L Stefanick; R T Chlebowski; D S Lane; J Wactawski-Wende; S Wassertheil-Smoller; T E Rohan
Journal:  Int J Obes (Lond)       Date:  2016-10-17       Impact factor: 5.095

3.  Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.

Authors:  Jian-Qin Zhang; Hui Geng; Mao Ma; Xun-Yi Nan; Bin-Wu Sheng
Journal:  Med Sci Monit       Date:  2015-08-14

4.  Biochemical changes in blood of type 2 diabetes with and without metabolic syndrome and their association with metabolic syndrome components.

Authors:  Fouzieh Zadhoush; Masoumeh Sadeghi; Morteza Pourfarzam
Journal:  J Res Med Sci       Date:  2015-08       Impact factor: 1.852

5.  Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.

Authors:  Yun-Hung Chen; Yu-Chien Lee; Yu-Chung Tsao; Mei-Chun Lu; Hai-Hua Chuang; Wei-Chung Yeh; I-Shiang Tzeng; Jau-Yuan Chen
Journal:  BMJ Open       Date:  2018-05-03       Impact factor: 2.692

6.  The Association between Oligomenorrhea, Onset of Menopause and Metabolic Syndrome in Thai Postmenopausal Women.

Authors:  Siripen Ongsupharn; Tawiwan Pantasri; Worashorn Lattiwongsakorn; Nuntana Morakote
Journal:  J Menopausal Med       Date:  2018-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.